Anxiety News and Research

Latest Anxiety News and Research

D-cycloserine may improve behavioral therapy treatment for anxiety

Anxiety is a normal human response to stress, but in some, it can develop into a disabling disorder of excessive and irrational fears, such as obsessive-compulsive disorder, panic disorder, or posttraumatic stress disorder. Effective treatments are available and can involve either behavioral therapy or medications.

16 Jul 2008

Forensic psychiatric inpatients with tattoos are significantly more likely to suffer from ASPD

The presence of tattoos on forensic psychiatric inpatients should alert clinicians to a possible diagnosis of Antisocial Personality Disorder (ASPD), and also about the potential for histories of suicide attempt, substance abuse, and sexual abuse, according to research published in the UK Journal 'Personality and Mental Health'.

16 Jul 2008

New ways of exploiting medicinal uses of cannabis

Research exploring new ways of exploiting the full medicinal uses of cannabis while avoiding unwanted side-effects will be presented to pharmacologists Tuesday, 15 July by leading scientists attending the Federation of European Pharmacological Societies Congress, EPHAR 2008.

From The University of Manchester 15 Jul 2008

Study reveals potential reasons for truancy and school fear

A questionnaire of Swiss schoolchildren has revealed the extent of truancy and school fear. The research, published in BioMed Central's open access journal Child and Adolescent Psychiatry and Mental Health, links truancy and school fear to life events, parental behaviour and school environment.

10 Jul 2008

Researchers identify brain cells related to fear - paves way for more effective PTSD treatments

The National Institute of Mental Health estimates that in any given year, about 40 million adults (18 or older) will suffer from some form of anxiety disorder, including debilitating conditions such as phobias, panic disorders and post-traumatic stress disorder (PTSD). It is estimated that nearly 15 percent of U.S. soldiers returning from Iraq and Afghanistan develop PTSD, underscoring the urgency to develop better treatment strategies for anxiety disorders.

10 Jul 2008

Genetic change in dopamine transporter supports a role for dopamine signaling in ADHD

A genetic change in the dopamine transporter - one of the brain's dopamine-handling proteins - makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.

9 Jul 2008

Mothers and fathers of twins report more mental health symptoms than parents of singletons

Mothers and fathers of twins conceived either spontaneously or with assisted reproductive technology (ART) suffer more mental health symptoms after delivery and one year later than do parents of singleton babies, according to research presented to the 24th annual meeting of the European Society of Human Reproduction and Embryology in Barcelona today (Monday).

7 Jul 2008

Experts say cognitive behavioural therapy effectiveness a 'myth'

According to experts the effectiveness of cognitive behavioural therapy (CBT) is a myth, and it is in no way superior to other methods.

7 Jul 2008

Effects of magic mushrooms long-lasting

Researchers in the United States say the "spiritual" effects of sacred mushrooms can last for more than a year.

2 Jul 2008

Healing touch therapy

Often, a gentle hand on your shoulder when you're upset is all it takes to ease your mind and calm your nerves. Now, University of Cincinnati (UC) researchers are looking at a similar occurrence by pairing a complementary therapy known as Healing Touch with mild sedation to see if the technique truly calms patients undergoing minor procedures.

1 Jul 2008

Spiritual effects of 'sacred mushrooms' appear to last more than a year

In a follow-up to research showing that psilocybin, a substance contained in "sacred mushrooms," produces substantial spiritual effects, a Johns Hopkins team reports that those beneficial effects appear to last more than a year.

1 Jul 2008

Neural stem cell development may be linked to Autism

In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism.

30 Jun 2008

Stillbirths, infant deaths lead to anxiety, guilt among obstetricians

Nearly one in 10 obstetricians in a new study has considered giving up obstetric practice because of the emotional toll of stillbirths and infant deaths.

30 Jun 2008

Many adults distrust youngsters

A survey carried out in the UK has revealed mounting concern regarding the moral values of children.

30 Jun 2008

Children today are happier, less anxious and more sociable

According to new research from the Australian Institute of Family Studies, children today are less anxious, more sociable and are happier than children were 20 years ago.

30 Jun 2008

Combination of cognitive-behaviour therapy and d-Cycloserine provides new hope for sufferers of social anxiety

Young people and adults who experience social anxiety may benefit from a revolutionary new study being carried out at the University of Sydney.

30 Jun 2008

Controversial diet drug Rimonabant now available on the NHS in Britain

A controversial diet drug has been approved for use on the National Health Service (NHS) in Britain.

24 Jun 2008

Canada's mental health crisis

No one is safe from mental illness; it strikes without regard for age, gender, or social status. And even though one in four Canadians suffer from a mental illness, it remains a stigma, shrouded in misconceptions.

24 Jun 2008

Hunger hormone ghrelin increases during stress, may have antidepressant effect

New research at UT Southwestern Medical Center may explain why some people who are stressed or depressed overeat.

24 Jun 2008

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

16 Jun 2008